Skip to main content
. Author manuscript; available in PMC: 2016 May 18.
Published in final edited form as: Mod Pathol. 2015 Oct 2;28(12):1603–1612. doi: 10.1038/modpathol.2015.115

Table 1.

DICER1 hotspot mutations identified in ovarian and testicular sex cord-stromal tumors and female genital tract tumors.

Tumor type n DICER1 hotspot mutant (n) p.E1705K (c.5113G>A) (n) p.D1709N (c.5125G>A) (n) p.E1813Q (c.5437G>C) (n) p.G1809R (c.5658G>A) (n)
Sertoli-Leydig cell tumor (all) 32 20 (63%) 16 1 2 1
Well-differentiated Sertoli-Leydig cell tumor 2 0 (0%)
Intermediately-differentiated Sertoli-Leydig cell tumor1 20 14 (70%) 13 1
 Sertoli-Leydig cell tumor with gastrointestinal-type heterologous 4 3 (75%) 3
 Sertoli-Leydig cell tumor with retiform features 6 3 (50%) 2 1
Poorly-differentiated Sertoli-Leydig cell tumor2 10 6 (60%) 3 1 2
 Sertoli-Leydig cell tumor with rhabdomyosarcomatous differentiation 4 3 (75%) 2 1
Gynandroblastoma 5 2 (40%) 2
Sertoli cell tumor 8 5 (63%) 5
Sex cord tumor with annular tubules 1 0 (0%)
Sex cord stromal tumor not otherwise specified 1 0 (0%)
Embryonal rhabdomyosarcoma (pediatric) 2 0 (0%)
Primary uterine rhabdomyosarcoma (adult) 4 1 (25%) 1
Carcinosarcoma with rhabdomyosarcomatous differentiation (adult) 4 1 (25%) 1
Testicular sex cord stromal tumor 15 0 (0%)
1

Tumor category includes Sertoli-Leydig cell tumors with retiform or gastrointestinal-type heterologous elements;

2

Tumor category includes Sertoli-Leydig cell tumors with rhabdomyosarcomatous elements.